Cargando…
Selenocystine-Derived Label-Free Fluorescent Schiff Base Nanocomplex for siRNA Delivery Synergistically Kills Cancer Cells
Chemo and siRNA synergic treatments for tumors is a promising new therapeutic trend. Selenocystine, a selenium analog of cysteine, has been considered a potential antitumor agent due to its redox perturbing role. In this study, we developed a nanocarrier for siRNA based on a selenocystine analog eng...
Autores principales: | Liu, Yang, Yang, Haoying, Liu, Qian, Pan, Mingming, Wang, Danli, Pan, Shiyuan, Zhang, Weiran, Wei, Jinfeng, Zhao, Xiaowei, Ji, Junfeng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8878402/ https://www.ncbi.nlm.nih.gov/pubmed/35209090 http://dx.doi.org/10.3390/molecules27041302 |
Ejemplares similares
-
Peptide-Based siRNA Nanocomplexes Targeting Hepatic Stellate Cells
por: Lin, Chien-Yu, et al.
Publicado: (2023) -
Cyclic Peptide-Gadolinium Nanocomplexes as siRNA Delivery Tools
por: Nasrolahi Shirazi, Amir, et al.
Publicado: (2021) -
Design of a Multicomponent Peptide-Woven Nanocomplex for Delivery of siRNA
por: Jun, Eunsung, et al.
Publicado: (2015) -
Reductive nanocomplex encapsulation of cRGD-siRNA conjugates for enhanced targeting to cancer cells
por: Zhou, Zhaoxiu, et al.
Publicado: (2017) -
Calcium-siRNA Nanocomplexes Optimized by Bovine Serum Albumin Coating Can Achieve Convenient and Efficient siRNA Delivery for Periodontitis Therapy
por: Wang, Yang, et al.
Publicado: (2020)